Cardinal/Bindley Aims To Pass McKesson In Revenues Without FTC Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
Cardinal's proposed acquisition of Bindley Western is an attempt to complete a deal large enough to pass McKesson as the top drug wholesaler but small enough to avoid scrutiny by the Federal Trade Commission.